What’s Vulnerable › Vulnerabilities

CVE-2022-26236

• Severity: medium (CVSS 5.5 v3.1)
• Exploited in the wild: not listed in CISA KEV
• EPSS: 0.2% probability of exploitation in the next 30 days
• Public exploit or detection template: none known
• Published: 2022-10-06 · updated 2026-06-17
• Weakness: CWE-732

Description

The default privileges for the running service Normand Remisol Advance Launcher in Beckman Coulter Remisol Advance v2.0.12.1 and prior allows non-privileged users to overwrite and manipulate executables and libraries. This allows attackers to access sensitive data.

Affected products

• Beckmancoulter Remisol Advance: through 2.0.12.1

References

• https://pastebin.com/hwrvFix5
• https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance
• https://pastebin.com/hwrvFix5
• https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance

Get alerted when CVE-2022-26236 or the next vulnerability affects your stack